Skip to content
✎ FeedbackNew here?

Rule lab Rule-lab verdicts are gauntlet arithmetic · descriptive, not a recommendation

Bottom lineWrite a rule; we run it through the same gauntlet as our own studies and tell you honestly if it works.

Read-only demo — synthetic numbers that show the verdict FORMAT, not a real run (the demo rule was judged WEAKER-THAN-BENCHMARK on purpose: the lab's job is honest refusal). The owner composes and queues real rules here.

SELECT RANK BY TAKE HOLD
WHERE
VETO (vetoes filter; they never rank — D66)
runs queue to the Review Inbox; the verdict lands here when done
rule SELECT liquid500 WHERE not_extended RANK BY mom12 TAKE 25 HOLD quarterly
WEAKER-THAN-BENCHMARK descriptive-only
net return/vol0.61
gross return/vol1.02
flat-cost return/vol0.84
max drawdown-41.0%
half 1 (2012-18)0.55
half 2 (2019-26)0.66
placebo p95?Placebo p95The 95th percentile of the null distribution: the same book rebuilt N times with RANDOM picks (same universe, same size, same costs). A rule must beat this, not merely beat zero — luck has a high bar. source: evlib placebo machinery via rule_lab_executor.Rule lab — the gauntlet vocabulary0.40
observed0.61
empirical p0.02
annual cost %6.00
turnover/rebalance0.38
benchmark (Nifty-500 net)0.89
capacity breakpoint?Capacity breakpointThe AUM (₹ cr) at which participation-cost impact kills the edge — the largest AUM whose net return/vol still beats the benchmark. A rule with no stated capacity is not a result. source: cost_participation grid scan.Rule lab — the gauntlet vocabularyunstated
prereg eb64d10999f899b4… · demo — synthetic numbers, not a real run · CSV
In plain EnglishPlain read: the verdict is the gauntlet's arithmetic on YOUR rule — walk-forward halves, a random-pick placebo, realistic costs, a capacity read — judged against Nifty-500 buy-and-hold. It is a statistical summary of the rule, not advice about any stock.

How the gauntlet judges

New here? How to read these charts →